Literature DB >> 19221866

Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility.

T Y Kim1, D Vigil, C J Der, R L Juliano.   

Abstract

DLC-1 was originally identified as a potential tumor suppressor. One of the key biochemical functions of DLC-1 is to serve as a GTPase activating protein (GAP) for members of the Rho family of GTPases, particularly Rho A-C and Cdc 42. Since these GTPases are critically involved in regulation of the cytoskeleton and cell migration, it seems clear that DLC-1 will also influence these processes. In this review we examine basic aspects of the actin cyoskeleton and how it relates to cell motility. We then delineate the characteristics of DLC-1 and other members of its family, and describe how they may have multiple effects on the regulation of cell polarity, actin organization, and cell migration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221866      PMCID: PMC2757774          DOI: 10.1007/s10555-008-9167-2

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  59 in total

1.  Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines.

Authors:  Nicole Euer; Marina Schwirzke; Vesna Evtimova; Helmut Burtscher; Michael Jarsch; David Tarin; Ulrich H Weidle
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

Review 2.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

Review 3.  Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration.

Authors:  Matthias Krause; Erik W Dent; James E Bear; Joseph J Loureiro; Frank B Gertler
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

Review 4.  Cell migration: integrating signals from front to back.

Authors:  Anne J Ridley; Martin A Schwartz; Keith Burridge; Richard A Firtel; Mark H Ginsberg; Gary Borisy; J Thomas Parsons; Alan Rick Horwitz
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

Review 5.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

6.  A multigenic program mediating breast cancer metastasis to bone.

Authors:  Yibin Kang; Peter M Siegel; Weiping Shu; Maria Drobnjak; Sanna M Kakonen; Carlos Cordón-Cardo; Theresa A Guise; Joan Massagué
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

7.  DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.

Authors:  Bao-Zhu Yuan; Xiaoling Zhou; Marian E Durkin; Drazen B Zimonjic; Katrin Gumundsdottir; Jorunn E Eyfjord; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

Review 8.  Integration of signals to the Arp2/3 complex.

Authors:  Alissa M Weaver; Michael E Young; Wei-Lih Lee; John A Cooper
Journal:  Curr Opin Cell Biol       Date:  2003-02       Impact factor: 8.382

9.  Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.

Authors:  Siân Jones; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; Hirohiko Kamiyama; Antonio Jimeno; Seung-Mo Hong; Baojin Fu; Ming-Tseh Lin; Eric S Calhoun; Mihoko Kamiyama; Kimberly Walter; Tatiana Nikolskaya; Yuri Nikolsky; James Hartigan; Douglas R Smith; Manuel Hidalgo; Steven D Leach; Alison P Klein; Elizabeth M Jaffee; Michael Goggins; Anirban Maitra; Christine Iacobuzio-Donahue; James R Eshleman; Scott E Kern; Ralph H Hruban; Rachel Karchin; Nickolas Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

10.  Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells.

Authors:  Xiaoling Zhou; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Oncogene       Date:  2004-02-12       Impact factor: 9.867

View more
  55 in total

1.  Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.

Authors:  Xuan Cao; Courtney Voss; Bing Zhao; Tomonori Kaneko; Shawn Shun-Cheng Li
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Tensin1 positively regulates RhoA activity through its interaction with DLC1.

Authors:  Yi-Ping Shih; Peng Sun; Aifeng Wang; Su Hao Lo
Journal:  Biochim Biophys Acta       Date:  2015-09-28

3.  The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.

Authors:  Pratima Basak; Rachelle Dillon; Heather Leslie; Afshin Raouf; Michael R A Mowat
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

4.  Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process.

Authors:  Yi-Ping Shih; Sarah Y Yuan; Su Hao Lo
Journal:  Cancer Lett       Date:  2017-04-10       Impact factor: 8.679

5.  DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity.

Authors:  Veenu Tripathi; Nicholas C Popescu; Drazen B Zimonjic
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

6.  Protected cytoskeletal-related proteins: Towards a resolution of contradictions regarding the role of the cytoskeleton in cancer.

Authors:  Daniel T Segarra; John M Yavorski; George Blanck
Journal:  Biomed Rep       Date:  2017-07-06

7.  Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger.

Authors:  Mamta Jaiswal; Radovan Dvorsky; Ehsan Amin; Sarah L Risse; Eyad K Fansa; Si-Cai Zhang; Mohamed S Taha; Aziz R Gauhar; Saeideh Nakhaei-Rad; Claus Kordes; Katja T Koessmeier; Ion C Cirstea; Monilola A Olayioye; Dieter Häussinger; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

8.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

9.  SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.

Authors:  Huiling He; Agnieszka Bronisz; Sandya Liyanarachchi; Rebecca Nagy; Wei Li; Yungui Huang; Keiko Akagi; Motoyasu Saji; Dorota Kula; Anna Wojcicka; Nikhil Sebastian; Bernard Wen; Zbigniew Puch; Michal Kalemba; Elzbieta Stachlewska; Malgorzata Czetwertynska; Joanna Dlugosinska; Kinga Dymecka; Rafal Ploski; Marek Krawczyk; Patrick J Morrison; Matthew D Ringel; Richard T Kloos; Krystian Jazdzewski; David E Symer; Veronica J Vieland; Michael Ostrowski; Barbara Jarząb; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

10.  Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform.

Authors:  Mohammad G Sabbir; Nichola Wigle; Shauna Loewen; Yuan Gu; Cordula Buse; Geoffrey G Hicks; Michael R A Mowat
Journal:  BMC Biol       Date:  2010-03-03       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.